Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer

AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

Oleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 37.1K citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin‐Dependent Kinases cdc2, cdk2 and cdk5

Laurent Meijer, Annie Borgne, Odile Mulner et al. · European Journal of Biochemistry · 1997 · 1.4K citations

Medicine, Cancer Biology, Oncology +15

The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers

Tadeusz Dyba, Giorgia Randi, Freddie Bray et al. · European Journal of Cancer · 2021 · 653 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis

Guido Bold, Karl‐Heinz Altmann, J Frei et al. · Journal of Medicinal Chemistry · 2000 · 213 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition

D.J. Wood, S. Korolchuk, Natalie J. Tatum et al. · Cell chemical biology · 2018 · 156 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12